Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3642091 | 0.94 | ALDH1A1 (0.38) | MAPTKDM4EMEN1KMT2AALOX15 | |
| SCHEMBL25213941 | 0.83 | HTT (0.33) | MAPTKMT2ATSHRALDH1A1HPGD | |
| SCHEMBL754466 | 0.82 | MAPT (0.39) | MAPTKDM4EMEN1KMT2AALOX15 | |
| SCHEMBL25208706 | 0.79 | MAPK1 (0.38) | MAPTKDM4EMEN1KMT2AALOX15 | |
| SCHEMBL25201852 | 0.74 | — | — | |
| SCHEMBL11528099 | 0.70 | MAPT (0.37) | MAPTKDM4EMEN1KMT2AALOX15 | |
| SCHEMBL3643846 | 0.69 | — | — | |
| SCHEMBL29275507 | 0.67 | KMT2A (0.35) | KMT2ATSHRALDH1A1HPGDHTT | |
| SCHEMBL3643855 | 0.66 | — | — | |
| SCHEMBL3642326 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4405323-B1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH & CIE (CH) | 2026-01-14 | — | — | EP | disclosed |
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2025-01-30 | — | — | US | disclosed |
| EP-4405323-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | Firmenich SA (CH) | 2024-07-31 | — | — | EP | disclosed |
| CN-118302402-A | Process for the preparation of cyclic dienes | 弗门尼舍有限公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2023094502-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2023-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | DHPS, FDFT1, CYP17A1 | MAPT 2999/4885KDM4E 3254/4885MEN1 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.